Global BloodStream Infection Testing Market, by Product Type (Instruments, Reagents, andOthers), by Technology (Conventional Testing and Non-conventional Testing), byTest Type (Conventional Blood Culture Tests, PCR Method, Nucleic Acid Testing,Mass Spectroscopy, and Point-of-Care Testing), by End User (Hospitals,Independent Diagnostics Centers, and Others), and by Region (North America,Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued atUS$ 3,758.7 million in 2017, and is projected to exhibit a CAGR of 8.4% overthe forecast period (2019 – 2026), as highlighted in a new report published by.
Increasing prevalence ofabdominal infection, dental infection, kidney and urinary infection, andchronic diseases is expected to augment the market growth Increasing prevalenceof abdominal infection and dental infection and growing geriatric populationare factors fueling the market growth. The Global Burden of Disease Study 2016estimated that oral disease affects half of the world’s population i.e. 3.58million people with dental carries. Globally it is estimated that 2.4 billionpeople suffer from carries of permanent teeth. Moreover, high incidences ofburns/wounds cases, HIV, pneumonia, pyelonephritis, and cancer along withgrowing awareness about hygiene is also expected to boost the global bloodstream infection testing market growth. According to World Health Organization,at the end of 2017, approximately 36.9 million people living with HIV and 1.8million people becoming newly infected in 2017 globally. Furthermore, advancements in diagnostictesting is expected to fuel the market growth over the forecast period.
* The sample copy includes:Report Summary, Table of Contents, Segmentation, Competitive Landscape, ReportStructure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/1727
For instance, in 2017,researchers from the University of Illinois and Charle Foundation Hospitalcompleted a clinical study of a device that can detect sepsis from a singledrop of blood. In April 2017, BioMérieux, a major player in the field of invitro diagnostics, announced that BacT/ALERT VIRTUO, its fully automated bloodculture system, received 510(k) clearance from the U.S. Food and Drug Administration(FDA). This innovative blood culture microbial detection system enhances theblood culture performance for rapid detection, thereby offering fasteridentification of bloodstream infection.
Browse 22 Market Data Tables and20 Figures spread through 178 Pages and in-depth TOC on “Blood Stream InfectionTesting Market”- Global Forecast to 2026, by Product Type (Instruments,Reagents, and Others), by Technology (Conventional Testing and Non-ConventionalTesting), by Test Type (Conventional Blood Culture Tests, PCR Method, NucleicAcid Testing, Mass Spectroscopy, and Point-of-Care Testing), by End User(Hospitals, Independent Diagnostics Centers, and Others), and by Region (NorthAmerica, Latin America, Europe, Asia Pacific, Middle East, and Africa)
Key players in the market arefocused on launching new tests for detection of various infectious diseases.For instance, in October 2018, Becton, Dickson and Company launched themolecular test to detect the tuberculosis and multidrug resistant tuberculosis.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/blood-stream-infection-testing-market-1727
Key Takeaways of the Blood StreamInfection Testing Market:
The global blood stream infectiontesting market is expected to exhibit a CAGR of 8.4% over the forecast period,owing to high prevalence of abdominal infections, dental infections, andchronic diseases
Among product type, theinstruments segment held dominant position in the blood stream infectiontesting market in 2018, owing to various new innovations by the key players forsynthesizing bloodstream infection tests to detect the infectious diseases.
Major companies operating in theglobal blood stream infection testing market include, bioMérieux SA,Becton,Dickinson and Company, AB Sciex, IRIDICA, Abbot Laboratories, CepheidInc., C. R. Bard, Inc., F. Hoffmann-La Roche AG, Nanoshpere, Dade Behring,AdvanDX, Siemens Healthcare.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/1727
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
